FDA Approved: NUVESSA — Supplemental Application (Exeltis USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NUVESSA (metronidazole) from Exeltis USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• NUVESSA (Metronidazole)

Snippet

SUPPL AP for NUVESSA (METRONIDAZOLE)